265 related articles for article (PubMed ID: 1370253)
1. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins.
Mittrücker HW; Fleischer B
Cell Immunol; 1992 Jan; 139(1):108-17. PubMed ID: 1370253
[TBL] [Abstract][Full Text] [Related]
2. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
3. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM
Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
5. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins.
Bierer BE; Golan DE; Brown CS; Herrmann SH; Burakoff SJ
Eur J Immunol; 1989 Apr; 19(4):661-5. PubMed ID: 2471647
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of T cell activation and adhesion functions by soluble CD2 protein.
Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA
Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660
[TBL] [Abstract][Full Text] [Related]
8. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
[TBL] [Abstract][Full Text] [Related]
9. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition.
Makgoba MW; Sanders ME; Shaw S
Immunol Today; 1989 Dec; 10(12):417-22. PubMed ID: 2482743
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH
Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126
[TBL] [Abstract][Full Text] [Related]
11. The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells.
Tiefenthaler G; Hünig T
Int Immunol; 1989; 1(2):169-75. PubMed ID: 2484882
[TBL] [Abstract][Full Text] [Related]
12. Requirement for both the CD3/T cell receptor complex and the CD2/lymphocyte function-associated antigen-3 adhesion system in monocyte-independent T cell activation by oxidized erythrocytes.
Prince HE
Immunol Invest; 1989; 18(9-10):1081-93. PubMed ID: 2482251
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling.
Wingren AG; Dahlenborg K; Björklund M; Hedlund G; Kalland T; Sjögren HO; Ljungdahl A; Olsson T; Ekre HP; Sansom D
J Immunol; 1993 Aug; 151(3):1328-36. PubMed ID: 7687629
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
15. The LFA-3 adhesion pathway is differently utilized by superantigen-activated human CD4+ T-cell subsets.
Gjörloff A; Hedlund G; Kalland T; Sansom D; Fischer H; Trowsdale J; Sjögren HO; Dohlsten M
Scand J Immunol; 1992 Aug; 36(2):243-50. PubMed ID: 1380180
[TBL] [Abstract][Full Text] [Related]
16. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.
Chong AS; Staren ED; Scuderi P
Cancer Immunol Immunother; 1992; 35(5):335-41. PubMed ID: 1382856
[TBL] [Abstract][Full Text] [Related]
18. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
